Journal
OBESITY REVIEWS
Volume 18, Issue 10, Pages 1147-1158Publisher
WILEY
DOI: 10.1111/obr.12567
Keywords
Interleukin-15; obesity; type 2 diabetes mellitus
Categories
Funding
- National Basic Research Program of China [2013CB127305]
- Nature Science Foundation of Hunan Province [S2014J504I]
- Youth Innovation Promotion Association CAS [2016326]
- Major Project of Hunan Province [2015NK1002]
- Key Project of Research and Development Plan of Hunan Province [2016NK2170]
- Youth Innovation Team Project of ISA, CAS [2017QNCXTD_ZCS]
Ask authors/readers for more resources
Obesity rises rapidly and is a major health concern for modern people. Importantly, it is a major risk factor in the development of numerous chronic diseases such as type 2 diabetes mellitus (T2DM). Recently, interleukin (IL)-15 has attracted considerable attention as a potential regulator for the prevention and/or treatment of obesity and T2DM. The beneficial effects include increased loss of fat mass and body weight, improved lipid and glucose metabolism, reduced white adipose tissue inflammation, enhanced mitochondrial function, alterations in the composition of muscle fibres and gut bacterial and attenuated endoplasmic reticulum stress. Although these beneficial effects are somewhat controversial, IL-15, exogenously delivered or endogenously produced, may be a promising target in the prevention and treatment of obesity and T2DM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available